MassDevice

#OrthoInnovationTalks is back for Season 2, featuring emerging leader, Enovis, & we’re kicking things off with Group President of Reconstructive, Louie Vogt, as he takes us inside the company’s $1B+ reconstructive business & its rapid rise in #orthopedics. In this first episode, Vogt shares how #Enovis has evolved from DJO into a major player in the recon space through bold acquisitions & cutting-edge implant innovation. He breaks down: ✔️ How kinematically driven bearings & dual pivot #KneeDesigns are transforming patient outcomes ✔️ The expansion into #FootandAnkle reconstruction, one of the fastest-growing #ortho markets ✔️ The role of #robotics & #DigitalTech in reshaping #OrthopedicSurgery ✔️ What’s coming in 2025, including new launches in #shoulders, #hips, & extremities With a strong M&A strategy & breakthrough technology, Enovis is carving out a competitive edge in orthopedics. This conversation comes to you courtesy of our sponsor, Paragon Medical. Thank you! LISTEN to or WATCH the episode now, (link in comments) 🔽🔽🔽 #podcast #VideoPodcast #ReconstructiveSurgery #MedicalDevice #OrthoInnovation #Medtech Tom Salemi Kayleen Brown Sean Miller Enovis Foot & Ankle Enovis Surgical

The leaders in #respiratory disease continue to face some challenges but I'm encouraged by the small bits of progress we're seeing from #startups and smaller companies. 👏 Just this morning Sean Whooley of MassDevice reported on more good news from Lungpacer Medical, a company I've come to know and admire over the past few months. In fact, you can hear from the #neurostim company's senior technical team at #DeviceTalksBoston. Lungpacer has been on a winning streak of late: 🫁 Data backs Lungpacer Medical’s diaphragm neurostim 🫁 Lungpacer Medical wins FDA premarket approval for AeroPace neurostim system MassDevice also reported on success from AerWave, which is develop a lung denervation take to treat #COPD and #Asthma. 🫁 AerWave completes first-in-human study of lung denervation tech This space is interesting. In fact.,SoniVie Ltd, the #renaldenervation company that's being acquired by Boston Scientific, had a Chronic Obstructive Pulmonary Disease program at one point. But I can't confirm it's still active. 🫁 And finally, of course, there is Samay, which took top prize at the MedTech Innovator pitch competition at AdvaMed's anniual conference. CEO Maria Artunduaga, MD, MPH, MTM, is developing an AI-driven acoustic resonance platform for respiratory care and management. You can hear the story on a recent DeviceTalks Weekly podcast. Find all these links in the comments.

In this week’s episode of the #DeviceTalksWeekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia Systems, LLC CEO Patrick NJ Schnegelsberg & COO Matthew Schuster. Twenty years after FDA approval, #SynCardia is the only company with a commercially available total #ArtificialHeart, with more than 2,000 implants. Now they’re developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers. But before the interview, Host Tom Salemi gives a quick recap of the MassMEDIC Symposium and Gala. Then, Chris Newmarker & Senior Editor Danielle Kirsh unpack MassDevice’s new report on #SurgicalRobotic companies. LISTEN HERE: https://lnkd.in/esPJ67g2 #RoboticSurgery #cardiac #robotics #surgical #heart #cardiology

In this week’s episode of the #DeviceTalksWeekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia Systems, LLC CEO Patrick NJ Schnegelsberg & COO Matthew Schuster. Twenty years after FDA approval, #SynCardia is the only company with a commercially available total #ArtificialHeart, with more than 2,000 implants. Now they’re developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers. But before the interview, Host Tom Salemi gives a quick recap of the MassMEDIC Symposium and Gala. Then, Chris Newmarker & Senior Editor Danielle Kirsh unpack MassDevice’s new report on #SurgicalRobotic companies. LISTEN HERE: https://lnkd.in/esPJ67g2 #RoboticSurgery #cardiac #robotics #surgical #heart #cardiology

“Valve performance is critical for all patients, but the impact of poor valve performance is magnified in patients with a small aortic annulus, who are at risk of receiving a valve that is not adequate for their cardiac requirements." Go to MassDevice to find out more about Medtronic's new two-year #TAVR results. (I have the link in the comments below.) #cardiology #medtech #meddevice

A recent MassDevice analysis found that the top seven #surgicalrobotics companies that disclosed fundraising have brought in more than $2 billion in total. I've included them in a list of 10 #surgicalrobotics companies you need to know that I've just posted on the site. (And if you want to get a closer look at the fundraising totals, download MassDevice's Surgical Robotics Special Report.) I'll include links in the comments. #medtech #meddevice

From Asensus Surgical to Zimmer Biomet, discover information about 57 surgical robotics companies that have caught our attention at MassDevice. Download the free report: https://lnkd.in/eAy4HvPE #SurgicalRobotics #MedicalDevices #MedTech #RoboticSurgery

The latest #DeviceTalks Weekly podcast features a lot of Chris Newmarker. (Though, thanks to my colleague Tom Salemi for all of the editing.) I had a great interview recently with SynCardia Systems, LLC's CEO Patrick NJ Schnegelsberg (left) and COO Matthew Schuster (right) about the #artificialheart company's next-gen Emperor device under development. They're seeking to create a fully implantable version. For now, it still needs to have a battery on the outside, but there are no external drivers. It's exciting work. ... Also, I caught up really quick with Senior Editor Danielle Kirsh about our new Surgical Robotics Special Report on MassDevice. I have links to the DeviceTalks weekly podcast episode and the free report download in the comments. DeviceTalks #DeviceTalksPodcastNetwork #surgicalrobotics #cardiology #heartdisease #hearttransplant

The Federal Trade Commission is challenging a #privateequity firm's acquisition of Surmodics, Inc., claiming that the deal is anticompetitive because the acquirer also owns a majority stake in Biocoat. It's all about the hydrophilic medical device coatings market. Go to Medical Tubing + Extrusion and MassDevice for the details. (I'll include a link to the story in the comments.) #medtech #meddevice

Ronovo Surgical has received regulatory approval for its Carina laparoscopic surgical robotic platform in #China. “By overcoming limitations of conventional robotic surgery systems, we are enabling more hospitals and surgeons to unlock the potential of robotic-assisted surgery.” Associate Editor Sean Whooley has the details on MassDevice. (Link in the comments below.) #surgicalrobotics #roboticsurgery #medtech #meddevice